A Clinical Trial Agreement is a legally binding document that outlines the responsibilities of each party in a clinical trial.
This document is a template contract between a commercial sponsor and a research institution or individual clinical investigator to conduct a medical research study involving human subjects, containing provisions that are reasonable and consistent with standard industry practices.
This document is a template for a contract between a commercial sponsor and a research institution or individual clinical investigator to conduct a medical research study involving human subjects, with terms and provisions favoring the commercial sponsor.
This template provides a contract between a commercial sponsor and a research institution or individual clinical investigator to conduct a medical research study involving human subjects, with provisions for scope, responsibilities, compensation, compliance, confidentiality, IP ownership, and publication rights.
This Standard Clause provides an outline template form of representation for life sciences companies regarding their clinical trials to be included in underwriting contracts in a registered securities offering, with integrated notes and drafting tips.
This online document is a template for an FDA-regulated clinical trial informed consent that meets FDA requirements and industry standards.
This document provides a template letter for the transfer of ownership of an IND on file with the FDA, as well as a template letter for the new sponsor to accept the transfer and assume ownership, with integrated notes and drafting tips.
This template outlines the responsibilities of a company and a medical institution/individual clinical investigator/physician in supplying an investigational drug to treat a seriously ill patient under FDA's expanded access regulations.
This template contract provides a sample of an online document outlining the agreement between two parties for a human-subjects medical research study.
This template contract outlines the responsibilities and rights of two parties in a human-subject medical research study concerning a drug or biologic.
